336 results about "Medical food" patented technology

Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.

Milling dry extracts containing cocoa polyphenols (CPs) to reduce the particle size improves the flavor of edible products (e.g., foods, medical foods, nutritional supplements, and pharmaceuticals) or additives containing the milled cocoa extracts. The products, e.g., chocolates, are less astringent and less bitter. The mean particle size after milling is less than about 15 microns, preferably less than about 10 microns, and most preferably less than about 5 microns. The total CP content of the milled extracts is at least about 300 milligrams and preferably about 300 to about 700 milligrams per gram of milled extract. The additives consist essentially of (i) the milled high CP cocoa extract and (ii) a fat (e.g., cocoa butter), an oil (e.g., vegetable oil), or a syrup (e.g., corn syrup).

The present invention features sulfur-rich compositions and preparations thereof that are safe and effective as hydrogen sulfide prodrugs of high bioavailability. The invention also includes methods of treating pathological conditions associated with oxidative stress using sulfur-rich compositions. The invention further includes sulfur-rich compositions as antidotes and medical food for preserving and promoting general health.

The present invention is a grain product. The grain product includes a first fraction including bran. The first fraction is milled to a first particle size of less than 500 micrometers. The grain product also includes a second fraction including germ. The second fraction is milled to a second particle size of less than 500 micrometers. The grain product is at least one of: a food product, a nutritional supplement, a dietary supplement, a fiber supplement, a digestive supplement, a functional food, and a medical food.

Medical foods containing glycomacroprotein and additional supplemented amounts of arginine, leucine, and optionally other amino acids, such as tyrosine, are disclosed. The medical foods can be used to provide the complete protein requirements for patients having metabolic disorders such as phenylketonuria.

Compositions comprising a source of alkaline phosphatase that prevent or reduce toxic influx of lipopolysaccharide (LPS) through mucosal layers of a mamalian body cavity and methods of using these compositions for those purposes are disclosed. Such a source of alkaline phosphatase, preferably in a medical food such as infant milk formula, is eaten, drunk or otherwise administered for prophylaxis or treatment of LPS-mediated or LPS-exacerbated disease.

The botanical beverage is prepared with one of wolfberry fruit, aweto, ophiopogon root, American ginseng, cogongrass rhizome and other medical food plant material, and through conventional pre-treatment, cutting, pulping, adding water and heating, adding cellulase to extract, filtering to obtain plant extract, clarifying with pectinase and proteinase, cooling, high speed centrifugal filtering, ultrafiltering, high temperature sterilizing, hot filling and inclination turning, and cooling. The present invention has the advantages of high active component extracting rate, high stability, clearness, being transparent, high health effect, etc.

Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.

The invention relates to an anti-senescence medical food milk powder candy and making method, wherein the formulation comprises coix seed 5-40b, sesame seed 5-40b, kudzuvine root 5-40b, lotus seed 5-40b, apricot kernel 5-40b, ginseng 5-40b, astragalus root 5-40b, Chinese angelica root 5-40b, arborviate seed 5-40b (b is weight unit). The process for preparation comprises the steps of cleaning the constituents, ultramicro disintegrating, charging milk powder as carrying agent, stirring, tableting, packaging and inspecting.

The present disclosure provides methods for the production of enriched substances that can be used in the preparation of enriched food products, dietary supplements, medical foods, cosmetic products or pharmaceutical agents.

The invention relates to the method of treating metabolic syndrome in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue 1H216O. Further, invention relates to the medical food for treating metabolic syndrome in a mammal in need thereof which comprises water comprising from 99.76 to about 99.99 molecular % of isotopologue 1H216O. Further, invention relates to the use of water comprising from about 99.76 to about 99.99 molecular % of isotopologue 1H216O for the manufacture of a medical food for treating metabolic syndrome in a mammal in need thereof.

New iron preparations comprising stable, unpolymerized iron(III) citrate complex compositions and methods for their preparation are provided. Further, the invention involves the use stable, unpolymerized iron(III) citrate complex compositions of the invention as a food additive, nutritional supplement, dietary supplement, medical food, nutrient, iron fortificant, and source of iron in the fields of nutrition for humans, animals, fish, and birds and of diagnostics. The invention further involves the use of stable, unpolymerized iron(III) citrate complex compositions of the invention as a pharmaceutical and pharmacologically active ingredient for human clinical and veterinary applications.

Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.

The present invention discloses a preserved egg with Chinese Herbs, which is a preserved egg infiltrated with effective elements including Chinese Medical Herbs and aromatic condiment, wherein the Chinese Medial Herbs include one or more than one herbs as follows: liquorice, medlar, sealwort, dendrobe, eucommia bark, and angelica, and the aromatic condiment includes one or more than one materials as follows: aniseed, common fennel, cinnamon, clove, Zanthoxylum Bungeanum Maxin, and Amomum villosum Lour. The technical proposal of the processing includes that Chinese Medical Herbs and the aromatic condiment are mixed, smashed, extracted with supersonic wave, and filtrated to obtain an extract liquid; then fresh duck eggs are immersed in a preparation liquid for reserved eggs and put inside a jar to be bloated into the preserved eggs, the shells of which is peeled of; then the preserved eggs with the shells peeled off are immersed in the obtained extract liquid, heated and infiltrated to obtain the preserved eggs with Chinese Herbs, which are packaged in vacuum, sterilized to obtain the final product of the preserved eggs with Chinese Herbs. The present invention ameliorates the flavor of the preserved egg in the prior art, carries out greater improvements on the processing technics, the style of both the product and the package, and the sensible quality, etc, and provides a preserved egg with both better effect of medical food, but also better flavor.

Compositions, dietary supplements and medical foods for the treatment of symptoms of inflammatory disorders may include gamma-linolenic acid or dihomogammalinolenic acid, an inhibitor of Δ5 desaturase, and optionally stearidonic acid or ω−3 arachidonic acid. Preferred formulations may be in the form of a good tasting, preferably milk or fruit based drink, or a dried powder. Compositions reduce inflammation and inhibit increase in serum arachidonic acid associated with gamma-linolenic acid. The compositions of the invention may also be used for the treatment of cytokine mediated disorders in patients in need thereof.

Methods for the production of enriched plant polyphenols-dairy (e.g., milk) or polyphenols-ground edible material products that can be used in the preparation of functional foods, dietary supplements, medical foods, cosmetic products or pharmaceutical agents. The method of obtaining a polyphenol-dairy protein product comprising the steps of (a) combining a plant-derived polyphenol and a dairy product such as a dairy product comprising a protein, to form the polyphenol-dairy protein (e g, milk protein) product and a liquor; and (b) separating the polyphenol-dairy protein product from the liquor. In various embodiments, the plant-derived polyphenols and dairy product are a mixture of solid products, such as would be found in a dry composition. These methods also provide for the immobilization of these component(s) on the healthy, nutritious, and low-sugar food matrix provided by the ground edible material.

Milling dry extracts containing cocoa polyphenols (CPs) to reduce the particle size improves the flavor of edible products (e.g., foods, medical foods, nutritional supplements, and pharmaceuticals) or additives containing the milled cocoa extracts. The products, e.g., chocolates, are less astringent and less bitter. The mean particle size after milling is less than about 15 microns, preferably less than about 10 microns, and most preferably less than about 5 microns. The total CP content of the milled extracts is at least about 300 milligrams and preferably about 300 to about 700 milligrams per gram of milled extract. The additives consist essentially of (i) the milled high CP cocoa extract and (ii) a fat (e.g., cocoa butter), an oil (e.g., vegetable oil), or a syrup (e.g., corn syrup).

The invention discloses a combined wolfberry fruit solid beverage which can improve the constitution of the crowd with deficiency of yang and belongs to the technical field of medical foods. The solid beverage consists of the following components in parts by weight: 20-40 parts of wolfberry fruit extract, 40-60 parts of mulberry extract, 2-6 parts of rhizoma polygonati extract, 2-5 parts of lily extract, 1-3 parts of Chinese yam extract, 30-50 parts of corn isomalto-oligosaccharide and 40-80 parts of corn maltodextrin. The solid beverage does not have any harm to the human body, is good in mouthfeel, instant, convenient to eat and suitable for long-term drink, and the constitution of the crowd with deficiency of yang can be improved.

The invention discloses a nutriment for improving the immunity of patients suffering from tumors after operation, radiotherapy and chemotherapy and a preparation method of the nutriment, and belongs to the technical field of medical foods. The nutriment comprises 45-98g / L of protein, 22-48g / L of fat, 98-245g / L of carbohydrate, 0-18g / L of dietary fibers, 0.35-0.75g / L of vitamins, 3.6-7.2g / L of trace elements, 1.0-2.2g / L of nucleotide, 0.2-20g / L of arginine, 0-0.2g / L of taurine, and an appropriate amount of water. The nutriment has various nutrient components, is rich in glutamine, arginine, nucleotide, omega-stability fatty acid and the like, is scientific in proportion, improves the nutritional status of patients, improves the resistance power of patients during operation, and after operation, radiotherapy and chemotherapy, improves the immunity of organisms of the patients, controls the acute inflammation, protects the function of intestinal mucosal barrier, reduces complication, shortens hospital days and reduces treatment price.

Methods and compositions for preventing and / or treating degenerative joint diseases including osteoarthritis as well as inflammation of the joints and for diminishing associated pain are provided. The formulation includes glucosamine, conjugated linoleic acid and ascorbic acid. Methods of treatment are also provided. The compositions and methods can be provided as an over-the-counter drug, a nutritional supplement, a prescription medication or component thereof, or a functional or medical food or component thereof.

The invention discloses a composition for patients with chronic renal disease and preparing method thereof, and belongs to the technical field of medical food. The composition is prepared from, 33.4-58.6 g / l of protein, 62.5-123 g / l of fat, 204-305 g / l of carbohydrates, 5.0-20 g / l of dietary fiber, 0.14-0.68 g / l of phosphorus, 0.2-1.68 g / l of sodium, 0.2-2.00 g / l of potassium, 0.3-1.33 g / l of calcium, 0.04-0.30 g / l of magnesium, 1.0-2.25 mg RE / L of vitamin A, 4.6-8.6 mg RE / L of vitamin B complex, microelement, other vitamins, and water. The invention matches scientifically, and has high heat,low phosphorus ,sodium and potassium.The content of vitamin A is low while the content of vitamin B is high, conforming to the principle of nutrition support. The composition is easy to digest and is the main nutrient source of patients with chronic renal disease.

The present invention is directed to a particular arabinoxylan (“AX”) preparation and the finding that this preparation has a beneficial effect on the organization of the intestinal microbial community in the lumen and in particular at the site of the gut mucosa, where it modulates the barrier function of the intestinal surface, primarily by modulating the mucosa-associated microbial community towards a relative increase of health beneficial bacteria, such as bifidobacteria and lactobacilli. It is accordingly a first aspect of the present invention to provide said arabinoxylan preparation characterized in comprising isolated water-soluble arabinoxylans and the use thereof to improve functioning (e.g. barrier function) of the intestinal epithelium. Thus, in a further aspect the present invention provides compositions, both pharmaceutical and nutritional compositions, comprising said arabinoxylan preparations; in particular pharmaceuticals, medical foods, food supplements or food compositions, such as infant formula products, dairy products, bakery products or pastry products. The compositions optionally comprise probiotics such as Bifidobacterium or Lactobacillus.

The invention discloses a cinnamon and ginger solid beverage which can improve the constitution of the crowd with deficiency of yang and belongs to the technical field of medical foods. The solid beverage consists of the following components in parts by weight: 10-30 parts of dried ginger extract, 40-70 parts of Chinese date extract, 2-6 parts of cinnamon extract, 2-6 parts of longan extract, 1-4 parts of liquorice extract, 30-50 parts of corn isomalto-oligosaccharide and 40-80 parts of corn maltodextrin. The plants with the homology of medicine and food serve as a source for preparing the solid beverage, and the solid beverage does not have any harm to the human body, is good in mouthfeel, instant, convenient to eat and suitable for long-term drink, and the constitution of the crowd with deficiency of yang can be improved.

Described herein are compounds (including medical foods, pharmaceutical compositions, methods of compounding them), methods and systems for the diagnosis and / or treatment of prodromal schizophrenia. For example, described herein are methods of treating a developmentally-based neuropsychiatric disorder (schizophrenia) that includes first determining if a subject is at risk for such a disorder by examining phenotypical, serological immune markers and genotypical biomarkers. The biomarkers may be used to tailor the dose to be delivered by the medial food or pharmaceutical composition. Also described are compounds for treating prodromal (rather than full-blown) schizophrenia.

Preparations of glycan therapeutics, pharmaceutical compositions and medical foods thereof, optionally comprising micronutrients, polyphenols, prebiotics, probiotics, or other agents are provided and methods of making same. Also provided are methods of using said glycan therapeutics, e.g. for the modulation of human gastrointestinal microbiota and to treat dysbioses.

The invention discloses a composition for efficiently assistedly decreasing blood sugar, and a preparation method and an application thereof. The composition is composed of 400 to 500 parts by weight of a cyclocarya paliurus extract, 200 to 300 parts by weight of a horseradish tree leaf ultramicro wall-broken fine powder, 120 to 240 parts by weight of a mulberry leaf extract and 80 to 160 parts by weight of a bitter gourd extract. The content of cyclocarya paliurus total flavonoids is 8-16% and the content of polysaccharides is 12 to 28%; horseradish tree leaves are subjected to low-temperature airflow crushing to obtain the ultramicro wall-broken powder; the content of total flavonoids of the mulberry leaf extract is 2% to 15%, and the content of DNJ is 1% to 2%; the content of charantin of the bitter gourd extract is 5% to 20%. Tests indicate that the composition can significantly reduce the blood sugar of diabetic mice, can significantly enhance the glucose tolerance of the diabetic mice, and has important significance for research and development of hypoglycemic drugs, health food, functional ordinary food, special medical food and special dietary food.

The invention provides a fermented composition having a function for regulating and improving the immunity of a human body. The fermented composition is prepared from yeast beta-glucosan, functional oligosaccharide, probiotics and edible and medical food; and the edible and medical food is mainly prepared from the following raw materials in parts by weight: 10 to 45 parts of conifer cherry powder and 3 to 26 parts of cordyceps cephalosporium mycelia. The fermented composition is a novel fermented product and a fermented fungi bag for preparing enzymes; and the fungi bag is convenient to use and suitable for industrialized production and family-type production of various plant enzymes.

The invention relates to a medical food for regulating emotion through mutual promotion of five microorganism groups and a preparation method of the medical food. The medical food comprises five functional components of a neurotransmitter promotion group, a microorganism group, a prebiotic promotion group, a group for benefitting intelligence and invigorating the brain, and a metabolism repair group. The five functional components respectively have different functions, and are in interpromomtion effect, so that the mental emotion problems of anxiety, depression, disquieted symptoms and the like can be relieved in many respects. The healthy emotion is regulated, the willpower is strengthened, and the attention is improved, so that the purpose of being healthy in body and mind is realized, and sub-health of human bodies, caused by emotion and psychological causes can be relieved.

The present invention relates to dietary supplements, medical foods, or pharmaceutical compositions for use in the method of enhancement of cognitive function in healthy subjects and / or subjects person suffering from a cognitive deficit, comprising aqueous solution of a nutrient, wherein solution comprises a water having content of deuterium from 90 to about 135 ppm and 1H216O isotopologue up to 99.759%. In one embodiment of the invention relates to a succinate salt of choline as the nutrient.